Pompe disease is a progressive muscle disorder for which enzyme replacement therapy (ERT) has been available since 2006. The effects of ERT have been shown on distance walked, pulmonary function, and survival. We investigated whether ERT also improves quality of life and participation in daily life in adult patients with Pompe disease.
points per year [sp/y]; CI 95% −1.07 to −0.39), while it improved signifi cantly in the fi rst 2 years of ERT (1.49 sp/y ; CI 0.76 to 2.21), and remained stable thereafter. The Mental Component Summary measure (MCS) remained stable before and during ERT. After declining signifi cantly beforehand (−0.49 sp/y; CI −0.64 to-0.34), the RHS stabilized under ERT.
CONCLUSION
In adult patients with Pompe disease, ERT positively affects quality of life and participation in daily life. Compared with the progressive decline observed prior to treatment, physical health (PCS) improved and participation stabilized after starting ERT. Our results reinforce previous fi ndings regarding the effect of ERT on muscle strength, pulmonary function, and survival.
